Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Immunovant, Inc. is seeking an Executive Director of New Product Planning to lead the commercial strategy for lifecycle indications of IMVT-1402.
This role reports to the Chief Strategy Officer and directs a team through ideation to pre-launch build-out over ~24 months, coordinating with clinical, market research, and access teams. The position requires 15+ years in biotech/pharma, MBA or equivalent, and strong leadership, communication, and analytical skills.
Remote
Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.
The Role:
The Executive Director of New Product Planning is responsible for new product opportunity assessments and the commercial strategy for lifecycle indications of IMVT-1402. Reporting to the Chief Strategy Officer, this position leads commercial strategy and market development efforts for new products and follow-on indications from ideation through handoff to the launch team for build-out approximately 24 months pre-launch. Leading their team and partnering with commercial, the Executive Director will work to identify and prioritize potential new indications and manage commercial strategy for indications in development.
Key Responsibilities:
New Product Planning
Requirements:
Salary range for posting
$280,000 - $320,000 USD
Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.
For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.
As set forth in IMVT Corporation’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:
A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.
A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.